Streetbeat News

Analyst Ratings

ONTO

Benchmark analyst Mark Miller maintains a Buy rating on Onto Innovation (NYSE:ONTO) and raises the price target from $118 to $125.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 11:57 am

MRNS

Baird analyst Brian Skorney maintains an Outperform rating on Marinus Pharma (NASDAQ:MRNS), but lowers the price target from $24 to $20.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:56 am

DRIO

Alliance Global Partners analyst Ben Haynor maintains a 'Buy' rating on DarioHealth (NASDAQ:DRIO) but has lowered the price target from $5.45 to $4.1.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:55 am

YETI

Baird analyst Peter Benedict maintains an Outperform rating on YETI Holdings (NYSE:YETI) and raises the price target from $55 to $60.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:54 am

YETI

Baird analyst Peter Benedict maintains an Outperform rating on YETI Holdings (NYSE:YETI) and raises the price target from $55 to $600.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:54 am

TNYA

Canaccord Genuity analyst Whitney Ijem maintains a Buy rating on Tenaya Therapeutics (NASDAQ:TNYA) but lowers the price target from $18 to $17.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 11:53 am

WWW

Barclays analyst Jonathan Komp has maintained an Equal-Weight rating on Wolverine World Wide (NYSE:WWW) and lowered the price target from $13 to $10.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:52 am

MCHI

Nobel Prize-winning economist Paul Krugman has expressed concerns over China's economic situation, stating that the country's economic woes make it more dangerous to global security. He noted that China's GDP growth has now tapered to 4% and the country is trying to invest more than 40% of the GDP, which is not sustainable. He also mentioned that China's government has been resistant to reforms that might make its growth sustainable. The iShares MSCI China ETF (NASDAQ:MCHI), an index tracking Chinese stocks, fell 1.31% in premarket trading.

Portfolio Pulse from Shanthi Rexaline

August 11, 2023 | 11:51 am

TYRA

HC Wainwright & Co. analyst Mitchell Kapoor maintains a 'Buy' rating on Tyra Biosciences (NASDAQ:TYRA) and raises the price target from $17 to $20.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 11:51 am

MCK

Credit Suisse analyst A.J. Rice maintains an Outperform rating on McKesson (NYSE:MCK) and raises the price target from $450 to $485.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 11:48 am